Format

Send to

Choose Destination
Acta Neuropathol. 2018 Jul;136(1):167-169. doi: 10.1007/s00401-018-1864-5. Epub 2018 May 16.

Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation.

Author information

1
Center for Data Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, 3501 Civic Center Boulevard, Philadelphia, PA, 19104, USA.
2
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
3
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
4
Department of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
5
Meyer Children's Hospital, Florence, Italy.
6
Department of Pediatrics, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA.
7
Center for Data Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, 3501 Civic Center Boulevard, Philadelphia, PA, 19104, USA. WAANDERSA@email.chop.edu.
8
Department of Pediatrics, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA. WAANDERSA@email.chop.edu.
9
Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. WAANDERSA@email.chop.edu.
PMID:
29767381
PMCID:
PMC6015095
DOI:
10.1007/s00401-018-1864-5
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center